Treatment of pulmonary hypertension: Bench to bedside

Respiratory Medicine

Volumn 105, Issue SUPPL. 1, 2011, Pages

  Springer, Jochen ^a,b   Lainscak, Mitja ^a,c   Salobir, Barbara ^d   Lang, Irene M ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Drugs; Gene therapy; Pulmonary hypertension; Vascular remodeling; Vasodilators

Indexed keywords

AMBRISENTAN; ANGIOTENSIN CONVERTING ENZYME 2; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BONE MORPHOGENETIC PROTEIN; BOSENTAN; CAPTOPRIL; CARVEDILOL; CILAZAPRIL; ENALAPRIL; ENDOTHELIN RECEPTOR ANTAGONIST; ESCITALOPRAM; ESTRADIOL; GUANYLATE CYCLASE ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILOPROST; IMATINIB; MACITENTAN; METOPROLOL; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; PROSTACYCLIN RECEPTOR; RHO KINASE INHIBITOR; RIOCIGUAT; SELEXIPAG; SILDENAFIL; TADALAFIL; UNINDEXED DRUG; UNIPROST; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CLINICAL RESEARCH; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; DRUG TREATMENT FAILURE; GENE THERAPY; HUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TRANSLATIONAL RESEARCH;

ANTIHYPERTENSIVE AGENTS; COMORBIDITY; ENZYME ACTIVATION; GENE THERAPY; GUANYLATE CYCLASE; HUMANS; HYPERTENSION, PULMONARY; OXIDATIVE STRESS; QUALITY OF LIFE; RECEPTORS, ENDOTHELIN; RECEPTORS, EPOPROSTENOL; TRANSLATIONAL MEDICAL RESEARCH;

EID: 80055017386     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/S0954-6111(11)70004-X     Document Type: Article

References (41)

1. N Galie, MM Hoeper, M Humbert, A Torbicki, JL Vachiery, JA Barbera et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
2. GE D'Alonzo, RJ Barst, SM Ayres, EH Bergofsky, BH Brundage, KM Detre et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med 115 1991 343 349
3. L Taraseviciene-Stewart, Y Kasahara, L Alger, P Hirth, G Mc Mahon, J Waltenberger et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension FASEB J 15 2001 427 438 (Pubitemid 32141434)
4. N Davie, SJ Haleen, PD Upton, JM Polak, MH Yacoub, NW Morrell et al. ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells Am J Respir Crit Care Med 165 2002 398 405 (Pubitemid 34118516)
5. M Packer Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards Ann Intern Med 103 1985 258 270 (Pubitemid 15000581)
6. PJ Kadowitz, BM Chapnick, LP Feigen, AL Hyman, PK Nelson, EW Spannhake Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2 J Appl Physiol 45 1978 408 413 (Pubitemid 9181071)
7. T Higenbottam, D Wheeldon, F Wells, J Wallwork Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin) Lancet 1 8385 1984 1046 1047 (Pubitemid 14148935)
8. KH Ruan Advance in understanding the biosynthesis of prostacyclin and thromboxane A2 in the endoplasmic reticulum membrane via the cyclooxygenase pathway Mini Rev Med Chem 4 2004 639 647
9. CD Funk, L Furci, N Moran, GA Fitzgerald Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites Mol Pharmacol 44 1993 934 939 (Pubitemid 23344958)
10. M Gomberg-Maitland, VF Tapson, RL Benza, W McLaughlin, A Krichman, AC Widlitz et al. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension Am J Respir Crit Care Med 172 2005 1586 1589 (Pubitemid 43076550)
11. M Yanagisawa, H Kurihara, S Kimura, Y Tomobe, M Kobayashi, Y Mitsui et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415 (Pubitemid 18090241)
12. A Benigni Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies Curr Opin Nephrol Hypertens 4 1995 349 353
13. Y Takuwa, Y Kasuya, N Takuwa, M Kudo, M Yanagisawa, K Goto et al. Endothelin receptor is coupled to phospholipase C via pertussis toxin insensitive guanine nucleotide binding regulatory protein in vascular smooth muscle cells J Clin Invest 85 1990 653 658 (Pubitemid 20087465)
14. J Clarke, N Benjamin, W Larkin, DJ Webb, GJ Davies, A Maseri Endothelin is a potent long lasting vasoconstrictor in men Am J Physiol 257 1989 H2033 H2035
15. B Chua, CT Krebs, CC Chua, CA Diglio Endothelin stimulates protein synthesis in smooth muscle cells Am J Physiol 262 1992 E412 E416
16. RN Channick, O Sitbon, RJ Barst, A Manes, LJ Rubin Endothelin receptor antagonists in pulmonary arterial hypertension J Am Coll Cardiol 43 Suppl S 2004 62S 67S (Pubitemid 38759719)
17. KA Lucas, GM Pitari, S Kazerounian, I Ruiz-Stewart, J Park, S Schulz et al. Guanylyl cyclases and signaling by cyclic GMP Pharmacol Rev 52 2000 375 414
18. B Tantini, A Manes, E Fiumana, C Pignatti, C Guarnieri, R Zannoli et al. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells Basic Res Cardiol 100 2005 131 138 (Pubitemid 40361605)
19. J Wharton, JW Strange, GM Moller, EJ Growcott, X Ren, AP Franklyn et al. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells Am J Respir Crit Care Med 172 2005 105 113 (Pubitemid 40923321)
20. JD Corbin, A Beasley, MA Blount, SH Francis High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors Biochem Biophys Res Commun 334 2005 930 938 (Pubitemid 41033209)
21. N Galie, BH Brundage, HA Ghofrani, RJ Oudiz, G Simonneau, Z Safdar Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group Tadalafil therapy for pulmonary arterial hypertension Circulation 119 2009 2894 2903
22. RE Wrishko, J Dingemanse, A Yu, C Darstein, DL Phillips, Ml Mitchell Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects J Clin Pharmacol 48 2008 610 618 (Pubitemid 351503516)
23. AJ Peacock, NF Murphy, JJ McMurray, L Caballero, S Stewart An epidemiological study of pulmonary arterial hypertension Eur Respir J 30 2007 104 109 (Pubitemid 47074013)
24. DO Xu, Y Luo, Y Liu, J Wang, B Zhang, M Xu et al. Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats Respir Res 11 2010 182
25. JF Arnal, H Laurell, F Lenfant, V Douin-Echinard, L Brouchet, P Gourdy Estradiol action in atherosclerosis and reendothelial-ization Ernst Schering Found Symp Proc 1 2006 69 86
26. BW Fouty, B Grimison, KA Fagan, TD Le Cras, JW Harral, M Hoedt-Miller et al. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation Am J Respir Cell Mol Biol 25 2001 652 658 (Pubitemid 33087117)
27. K White, Y Dempsie, M Nilsen, AF Wright, L Loughlin, MR Maclean The serotonin transporter, gender, and 17p oestradiol in the development of pulmonary arterial hypertension Cardiovasc Res 90 2011 373 382
28. AJ Ferreira, V Shenoy, Y Yamazato, S Sriramula, J Francis, L Yuan et al. Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension Am J Respir Crit Care Med 179 2009 1048 1054
29. Y Imai, K Kuba, S Rao, Y Huan, F Guo, B Guan et al. Angiotensin- converting enzyme 2 protects from severe acute lung failure Nature 436 2005 112 116 (Pubitemid 40966195)
30. CN Bradford, DR Ely, MK Raizada Targeting the vasoprotective axis of the renin-angiotensin system: a novel strategic approach to pulmonary hypertensive therapy Curr Hypertens Rep 12 2010 212 219
31. BD Nossaman, VE Nossaman, SN Murthy, PJ Kadowitz Role of the RhoA/Rho-kinase pathway in the regulation of pulmonary vasoconstrictor function Can J Physiol Pharmacol 88 2010 1 8
32. HH Chung, ZK Dai, BN Wu, JL Yeh, CY Chai, KS Chu et al. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation Vascul Pharmacol 53 2010 239 249
33. TM Bull, CD Coldren, M Moore, SM Sotto-Santiago, DV Pham, SP Nana-Sinkam et al. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension Am J Respir Crit Care Med 170 2004 911 919 (Pubitemid 39359232)
34. O Sitbon, M Humbert, G Simonneau Primary pulmonary hypertension: Current therapy Prog Cardiovasc Dis 45 2002 115 128 (Pubitemid 35253678)
35. S Kanki-Horimoto, H Horimoto, S Mieno, K Kishida, F Watanabe, E Furuya et al. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension Circulation 114 1 Suppl 2006 l181 l185
36. YD Zhao, DW Courtman, DS Ng, MJ Robb, YP Deng, J Trogadis et al. Microvascular regeneration in established pulmonary hypertension by angiogenic gene transfer Am J Respir Cell Mol Biol 35 2006 182 189 (Pubitemid 44175317)
37. HC Champion, TJ Bivalacqua, K Toyoda, DD Heistad, AL Hyman, PJ Kadowitz In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-nduced pulmonary hypertension in the mouse Circulation 101 2000 923 930 (Pubitemid 30117889)
38. N Nagaya, K Kangawa, M Kanda, M Uematsu, T Horio, N Fukuyama et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells Circulation 108 2003 889 895 (Pubitemid 37022134)
39. T Ito, T Okada, J Mimuro, H Miyashita, R Uchibori, M Urabe et al. Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats Hypertension 50 2007 531 536 (Pubitemid 47312240)
40. AM Reynolds, W Xia, MD Holmes, SJ Hodge, S Danilov, DT Curiel et al. Bone morphogenetic protein type 2 receptor gene therapy attenuates hypoxic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 292 2007 L1182 L1192 (Pubitemid 47084862)
41. N Galie, A Manes, L Negro, M Palazzini, ML Bacchi-Reggiani, A Branzi A meta-analysis of randomized controlled trials in pulmonary arterial hypertension Eur Heart J 30 2009 394 403